Sub-Licensing Agreement For Oral Spleen Tyrosine Kinase Inhibitor Tavalisse With Tai Tien Pharmaceuticals In Taiwan
07/01/2025 06:31
Jan 7 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T :
* KISSEI PHARMACEUTICAL CO LTD: SUB-LICENSING AGREEMENT FOR
ORAL
SPLEEN TYROSINE KINASE INHIBITOR TAVALISSE WITH TAI TIEN
PHARMACEUTICALS IN TAIWAN
Source text: ID:nTSmg85a11
Further company coverage: 4547.T
(Reporting by Tokyo Newsroom)
((+81345201189;))